A Liver Biotech Drops Its Name and Reinvents Itself Around Gut Surgery
The company is now EoCene Ltd., built around a device that protects colorectal surgical joins. It also terminated its equity funding line — without saying why — and had cleared a Nasdaq warning just days before.